Wegener's granulomatosis: The current view

Frank Moosig, Peter Lamprecht*, Wolfgang L. Gross

*Corresponding author for this work
26 Citations (Scopus)


In the last few years, substantial progress has been achieved in elucidating the pathogenesis of Wegener's granulomatosis. Several genetic risk factors have been described. The structure of the granuloma and its possible function as ectopic lymphoid tissue have been defined. Furthermore, the consecutive immunopathological reactions leading to induction of PR3-antineutrophil cytoplasmic antibodies (ANCA) and the role of ANCA itself is getting clearer. However, the initial events leading to granuloma formation are still widely unknown. Concerning therapy, the significance of the so-called biological agents (TNF-α-blockers, Rituximab) still has to be defined.

Original languageEnglish
JournalClinical Reviews in Allergy and Immunology
Issue number1-2
Pages (from-to)19-21
Number of pages3
Publication statusPublished - 10.2008

Research Areas and Centers

  • Academic Focus: Center for Infection and Inflammation Research (ZIEL)


Dive into the research topics of 'Wegener's granulomatosis: The current view'. Together they form a unique fingerprint.

Cite this